针对CDC37辅导体和客户端基因酶之间的蛋白质-蛋白质相互作用,通过一个杂的英国皇家空军滴度破解器
bioRxiv : the preprint server for biology
|March 3, 2025
概括
布拉夫提德破坏了CDC37-激酶相互作用,导致RAF激酶的蛋白质体降解,并减少了癌细胞的增殖. 这揭示了一个新的治疗策略,针对酶 - 沙佩龙复合体.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 布拉夫提德是一种RAF激酶二聚干扰剂,也通过未知的机制诱导蛋白质体降解.
- CDC37是HSP90.0对激酶识别至关重要的共同监护者.
- 该RAF二元接口与CDC37-激酶结合基因 (αC-β4循环) 具有同质性.
研究的目的:
- 为了阐明布拉夫蒂德作用的双重机制.
- 为了研究Braftide的潜力,作为一种化学探测器,用于酶 - 沙龙相互作用.
- 评估针对CDC37-客户端激酶相互作用的治疗影响.
主要方法:
- 同免疫沉和NanoBiT测试证实了Braftide对CDC37-客户端激酶相互作用的破坏.
- 交换质谱学,分子动力学模拟,以及体外交叉连接来绘制结合点的地图.
- 癌症细胞系增殖和亡试验.
主要成果:
- 布拉夫提德选择性地破坏了CDC37的客户端激酶相互作用,节省了HSP90.
- 布拉夫提德结合会破坏RAF激酶客户端的稳定,从而诱导蛋白质体的降解.
- 布拉夫提德与HSP90抑制剂协同作用,导致复合物的增强不稳定.
- 破坏CDC37-RAF复合体会减少癌细胞的增殖,增加细胞亡.
结论:
- 布拉夫蒂德的双重功能源于破坏了CDC37的客户端激酶相互作用.
- 针对CDC37-客户端激酶相互作用是一种可行的治疗策略.
- αC螺旋-β4循环代表了下一代治疗开发的新型全位.
更多相关视频
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
相关概念视频
Restarting Stalled Replication Forks
5.7K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
Separation of Sister Chromatids
3.5K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
